Investment Q&A

Q: Peter; I asked last week - maybe it didn’t make it- about if buying LLY while owing Edwards would be duplication- or diversification ? Thanks.
Rod

Q: Repligen is trading close to the 52-week low and would welcome your analysis of their recent operating performance and market potential looking forward.  Post-pandemic and mindful of competitors in the same space does their stock have any opportunity to excel in the coming year, and if held as a position in a long-term growth portfolio, could you please rank the appeal of Repligen in descending order versus your go-to favorites in the same general space.  Thanks kindly for your thoughts.

Q: Hi team,

Grateful if you could provide a list of your top growth stocks, ten Canadian and ten American, for the next 2-3 years, excluding “lottery tickets”, with short comments and a risk evaluation. Please deduct as many credits as you see fit.

Thank you for the good work,

Jacques IDS

Q: With LLY just acquiring Sigilon Therapy and having some possible game-changing drugs in the pipeline for 2023 could I take a position here with a 5-year time horizon?

Thanks, Lesley

Q: Hi Folks,
I am looking to add ABT to my TFSA. I have PFE, ABBV and GILD in other accounts. Can I have your opinion on ABT or do you have another name that you can suggest for my TFSA.
Thanks

Q: Hi 5i,
What are your current thoughts on continuing to hold onto ILMN given the current situation with Grail and activist investor involvement?

If I were to sell what would you recommend in the U.S. Healthcare Sector?
I currently own ABBV, IHI, TMO and WELL.

Thank you!!

Q: Hi 5i,

For Guardant Health (GH) would you recommend holding or selling at this time?

If selling is your recommendation please provide 5 US healthcare stocks that have good prospects in the near to long term.

Thank you.

Q: hi, portfolio analytics says I am underweight basic materials, consumer defensive, healthcare and industrials. can you provide a few Canadian and US equities in each category, that you would consider for medium to long term investment.
cheers, chris ( take as many credits as you need ).
further, I am overweight in utilities ( 18.6% of total holdings ) and financials ( 25.5 %). do you recommend trimming these 2 sectors? and in financials I own BN and BAM ( which I would suspect actually have cross-over with other sectors? )??
cheers, chris

Q: Since the healthcare sector in Canada is quite limited, I would like to explore the option of purchasing 100% US healthcare stocks to better represent this sector. I would greatly appreciate it if you could suggest six stocks that I should consider. Thank you in advance.

Q: I have owned ENB for 6 years / it continues to disappoint. Russ Healy was on BNN saying net overall asset value continues to drop in the last 5 year's and i agree with him as my performance is negative (down 6% in the last 5 years, (this is excluding the dividend . Kindly explain how you continue to recommend this stock as it clearly is a loser in value the dividend is its only advantage... would TRP not be a better risk return or even Fortis / one of the pipes for that matter Thanks for your help with this . Lastly what is your top 3 picks in the health care sector

Q: What US Healthcare stock or ETF would you recommend to replace ABBV?

Q: As I'm sure you're aware, this is a name that has been drifting steadily lower since it ranked on its disappointing latest earnings release. Do you think it remains a premier us drug manufacturer worth holding or would you recommend redeploying the capital into another name?

Q: In the US healthcare space, I am looking for a value priced name with meaningful upside total return potential (3 to 5 years) ideally with some current yield. Am thinking ABBV but not sure if I should be looking at pure play pharmaceutical, equipment mfg or..? CVS already owned
Thoughts please on above or others, and thanks

Q: Do not own either, but would like to own both, any problem buying them now?
Thanks Again

Q: Is inflation finally under control?
Will we have a recession? How deep could it be?
Are our banks safe?
Are we losing control of our country to others that seem to play by different rules? We just kicked a Chinese diplomat out of Canada for threatening the family of a member of the Canadian parliament. How will China retaliate?
Russia is still at war against Ukraine. How is that impacting the world economy?
Climate change is threatening economies in counless ways. Almost all negative.

So here's my question. In your opinion, what Canadian and global companies offer a service so necessary or a product that is in such high demand that they will persevere in these troubled times and make profits for their investors?

Q: I hold JNJ, PFE and CVS in the health care sector. Are JNJ and PFE sufficiently different to warrant holding both? Would you recommend an alternative (and for which one)?

Q: I have held this stock for a few years and I am getting impatient. I guess I bought it at the wrong time, I am considering getting out. If I do exit do you have another health care company that you would recommend. Your overall thoughts please. Thanks

Q: I currently own ABBV. I am aware of the off-patent cliff for Humira. Earnings are expected to drop when they are announced at the end of this month. I'm not so sure their other two drugs - Rinvoq and Skyrizi - will be capable of picking up the slack. I had read a recent article, and it gave me the impression that Humira and its new biosimilar competitors have some active ingredient(s) that allows them to be used for patients using Rinvoq and Skyrizi (?) In other words, I'm wondering if the upside of Rinvoq and Skyrizi is limited. I think you like ABBV, but is there any concern longterm? The market doesn't appear to be pricing in the risks.

I've pared back some of my ABBV shares, and am considering selling the rest. Alternatively, how robust is Amgen's pipeline in comparison ? LLY looks historically expensive, and I already own JNJ.

Q: Thanks to strong performance largely from CSU and KXS, I am both overweight in Tech and also have outsized positions in both - CSU along with the spin offs is ~13% of total now.

While I like to let the winners run this position feels too oversized and would appreciate considerations around taking some earnings off here . Since I am also underweight in Industrials, Utilities, and Healthcare what would be good long term options here (I'm 41) to transition into?

Q: I have 4% of my RRSP in cash. Im underweight industrials and healthcare. I’m a fan of LLY for HC and J for industrial (WSP is my other). Would you add to these at current prices to get to a half position in each?